Nihon Kohden Completes Interim Review of Consolidated Financial Results

Interim Review Completion

Nihon Kohden Corporation, a prominent player in the medical device industry, has successfully completed the interim review of its consolidated financial results for the first half of the fiscal year ending March 31, 2024 1

1

. The review was conducted by certified public accountants and audit corporations, adding credibility to the company's financial reporting.

Financial Results Overview

The reviewed financial results cover the period from April 1, 2023, to September 30, 2023. Nihon Kohden's performance during this period reflects the company's operations in the challenging healthcare market 2

2

. The completion of this review process is a crucial step in providing transparent and accurate financial information to stakeholders.

Importance of the Interim Review

The interim review serves several important purposes:

1. Ensuring Accuracy: It helps verify the accuracy of the financial statements, providing assurance to investors and regulatory bodies 1

   1

   .
2. Compliance: The review ensures that Nihon Kohden's financial reporting complies with Japan GAAP (Generally Accepted Accounting Principles) 2

   2

   .
3. Transparency: It demonstrates the company's commitment to transparency in its financial dealings.

Impact on Stakeholders

The completion of this review is significant for various stakeholders:

1. Investors: It provides them with reliable financial information to make informed decisions about their investments in Nihon Kohden 2

   2

   .
2. Regulatory Bodies: It assures compliance with financial reporting standards and regulations.
3. Company Management: It offers an external perspective on the company's financial health and reporting practices.

Looking Ahead

While the interim review provides a snapshot of Nihon Kohden's financial position for the first half of the fiscal year, it also sets the stage for the company's performance in the latter half. Stakeholders will be keenly watching how these results translate into full-year performance and strategic decisions by the company 1

1

2

2

.

As the medical device industry continues to evolve, Nihon Kohden's financial stability and transparency will play crucial roles in maintaining its market position and investor confidence. The completion of this interim review marks an important milestone in the company's fiscal year and its ongoing commitment to financial integrity.